Chronobiotics

Time-Shifting Medicines

References for this website


From Chronobiology to Chronomedicine: Early Days

Toward a classification of medications for sleep and circadian rhythm disorders. - Michael J Thorpy and Thomas Roth

Malcolm von Schantz, Debra J Skene, Telling biological time from a blood sample: current capabilities and future potential. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2015

Arendt J. Managing jet lag: Some of the problems and possible new solutions. Sleep Med Rev. 2009 Aug;13(4):249-56. Epub 2009 Jan 14. [doi] 10.1016/j.smrv.2008.07.011

Berra B et al. Melatonin: circadian rhythm regulator, chronobiotic, antioxidant and beyond. Clin Dermatol. 2009 Mar-Apr;27(2):202-9. [doi] 10.1016/j.clindermatol.2008.04.003

Cardinali DP et al. Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent. Ann N Y Acad Sci. 2005 Dec;1057:327-36. [doi] 10.1196/annals.1356.025

Caumo W et al. The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg. 2007 Nov;105(5):1263-71, table of contents. [doi] 10.1213/01.ane.0000282834.78456.90

Circadian Rhythm Disorders. The Cleveland Clinic. Available at: http://clevelandclinic.org/sleep Accessed July 21, 2009.

Escames G et al. [Melatonin, synthetic analogs, and the sleep/wake rhythm]. Rev Neurol. 2009 Mar 1-15;48(5):245-54.

Everett M. All Natural Sleep Aid Supplements Reviewed: How Well Do They Work? Available at: http://www.mednewscentral.com/InsomniaAlternatives.htm?source=google/Alteril Accessed July 28, 2009.

Guardiola-Lemaitre B. [Melatoninergic receptor agonists and antagonists: therapeutic perspectives]. J Soc Biol. 2007;201(1):105-13.

Hardeland R et al. Melatonergic drugs in clinical practice. Arzneimittelforschung. 2008;58(1):1-10.

Hardeland R. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatonergic agonists. Neuropsychiatr Dis Treat. 2009;5:341-54. Epub 2009 Jun 10.

Mahmoud F et al. The therapeutic application of melatonin in supportive care and palliative medicine. Am J hosp Palliat Care. 2005 Jul-Aug;22(4):295-309.

Maldonado MD et al. the potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res. 2007 Jan;42(1):1-11. [doi] 10.1111/j.1600-079X.2006.00376.x

Melatonin. Iowa State University: University Extension. Available at: http://www.extension.iastate.edu/nutrition/supplements/melatonin.php. Accessed July 26, 2009.

The Merck Manual, 18th Ed. 2006; Merck & Co, Inc; Whitehouse Station, NJ.

Pandi-Perumal SR et al. Ramelteon: a review of its therapeutic potential in sleep disorders. Adv Ther. 2009 Jun;26(6):613-26. Epub 2009 Jun 30. [doi] 10.1007/s12325-009-0041-6

Peres MF et al. Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs. 2006 Apr;15(4):367-75. [doi] 10.1517/13543784.15.4.367

Schwartz JR et al. Shift work sleep disorder: burden of illness and approaches to management. Drugs. 2006;66(18):2357-70. [pii] 66187

Skidmore-Roth L. Mosby’s Handbook of Herbs & Natural Supplements, 3rd Ed. 2006; Mosby Inc; St. Louis, MO.

Srinivasan V et al. Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci. 2009;119(6):821-46. [doi] 10.1080/00207450802328607

Taber’s Cyclopedic Medical Dictionary, 21st Ed. 2009; F.A. Davis Company; Philadelphia, PA.

van Heukelom RO et al. Influence of melatonin on fatigue severity in patients with chronic fatigue syndrome and late melatonin secretion. Eur J Neurol. 2006 Jan;13(1):55-60. [doi] 10.1111/j.1468-1331.2006.01132.x

Witt-Enderby PA et al. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy. J Pineal Res. 2006 Nov;41(4):297-305. [doi] 10.1111/j.1600-079X.2006.00369.x

Zemlan FP et al. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial. J Clin Psychiatry 2005;66(3):384-390.

Toward a classification of medications for sleep and circadian rhythm disorders.

Melatonin and its agonists: an update - British Journal of Psychiatry

Chronopharmacology: New Insights and Therapeutic Implications

 


The Chrconobiotics book is available in Kindle format from Amazon:

.